We are live on ! Find out more
Osaic Holdings

Osaic Holdings Portfolio holdings

AUM $68.3B
1-Year Est. Return 20.5%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+20.5%
3 Year Est. Return
+61.22%
5 Year Est. Return
+69.4%
10 Year Est. Return
AUM
$55.7B
AUM Growth
+$2.54B
Cap. Flow
-$51.9M
Cap. Flow %
-0.09%
Top 10 Hldgs %
16.64%
Holding
7,764
New
258
Increased
2,865
Reduced
3,228
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHTA
5501
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$21.2K ﹤0.01%
3,000
+718
+31% +$5.13K
KLAC icon
5502
CALL
KLA
KLAC
$259B
$21.2K ﹤0.01%
10
THRY icon
5503
Thryv Holdings
THRY
$110M
$21.2K ﹤0.01%
860
+121
+16% +$2.81K
IREN icon
5504
Iris Energy
IREN
$14.1B
$21.1K ﹤0.01%
3,000
BLPH
5505
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$21.1K ﹤0.01%
30,614
+29,614
+2,961% +$191K
GAN
5506
DELISTED
GAN Ltd
GAN
$21K ﹤0.01%
12,822
-894
-7% -$1.27K
GINN icon
5507
Goldman Sachs Innovate Equity ETF
GINN
$210M
$21K ﹤0.01%
427
TBCH
5508
Turtle Beach Corp
TBCH
$280M
$21K ﹤0.01%
1,802
+336
+23% +$3.75K
PESI icon
5509
Perma-Fix Environmental Services
PESI
$389M
$20.9K ﹤0.01%
1,900
-900
-32% -$9.38K
GORO icon
5510
Goldgroup Mining Inc.
GORO
$184M
$20.9K ﹤0.01%
33,098
-3,391
-9% -$3K
RLJ icon
5511
RLJ Lodging Trust
RLJ
$1.75B
$20.9K ﹤0.01%
2,025
-746
-27% -$7.75K
IVAL icon
5512
Alpha Architect International Quantitative Value ETF
IVAL
$224M
$20.8K ﹤0.01%
876
+4
+0.5% +$93
GTHX
5513
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$20.8K ﹤0.01%
8,364
+3,571
+75% +$9.76K
ATNM icon
5514
Actinium Pharmaceuticals
ATNM
$25.1M
$20.8K ﹤0.01%
2,816
FORR icon
5515
Forrester Research
FORR
$225M
$20.7K ﹤0.01%
713
+312
+78% +$9.28K
OCUL icon
5516
Ocular Therapeutix
OCUL
$1.96B
$20.7K ﹤0.01%
4,012
-945
-19% -$5.62K
IMOS
5517
ChipMOS TECHNOLOGIES
IMOS
$1.83B
$20.6K ﹤0.01%
869
+89
+11% +$2.23K
PIM
5518
Franklin Master Intermediate Income Trust
PIM
$151M
$20.6K ﹤0.01%
6,520
-5,308
-45% -$16.7K
KPLT icon
5519
Katapult Holdings
KPLT
$32.8M
$20.6K ﹤0.01%
915
-36
-4% -$545
MCSE
5520
DELISTED
Franklin Sustainable International Equity ETF
MCSE
$20.5K ﹤0.01%
1,404
MDEV icon
5521
First Trust Indxx Medical Devices ETF
MDEV
$3.08M
$20.5K ﹤0.01%
980
KEMQ icon
5522
KraneShares Public-Private Emerging Markets Internet and Technology ETF
KEMQ
$26.2M
$20.5K ﹤0.01%
1,418
-504
-26% -$7.38K
MRAM icon
5523
Everspin Technologies
MRAM
$408M
$20.5K ﹤0.01%
2,230
AOUT icon
5524
American Outdoor Brands
AOUT
$160M
$20.5K ﹤0.01%
2,364
-171
-7% -$1.42K
AMNB
5525
DELISTED
American National Bankshares Inc
AMNB
$20.5K ﹤0.01%
715
-40
-5% -$1.15K

Similar funds

Osaic Holdings's Q2 2023 Portfolio in Review

As of Q2 2023, Osaic Holdings held 7,764 positions worth $55.7B, up 4.8% from $53.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Osaic Holdings's Q2 2023 filing shows 258 new, 2,865 increased, 3,228 reduced and 304 closed positions. Its largest new stake was Invesco International Developed Dynamic Multifactor ETF: 509,214 shares worth $12.3M. The largest sale was iShares 7-10 Year Treasury Bond ETF, an estimated $133M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.

  • Osaic Holdings's largest Q2 2023 buy was Invesco International Developed Dynamic Multifactor ETF: 509,214 shares worth $12.3M.
  • Osaic Holdings added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2023, an estimated $132M increase.
  • Osaic Holdings's biggest Q2 2023 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $133M.
  • Osaic Holdings fully exited SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML) in Q2 2023, selling an estimated $9.4M.
  • Osaic Holdings's ten largest holdings make up 17% of its $55.7B portfolio in Q2 2023.
  • Osaic Holdings opened 258 new positions and closed 304 in Q2 2023.
  • Osaic Holdings's portfolio value rose 4.8% quarter-over-quarter to $55.7B.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.